PerkinElmer launches pre-eclampsia screening assay in EU
This article was originally published in Clinica
PerkinElmer (Waltham, Massachusetts) has launched its DELFIA Xpress PlGF Assay in the EU, for the early detection of pre-eclampsia in pregnant women. It is the first placental growth factor assay kit designed to screen pregnant women for early-onset pre-eclampsia during their first trimester of pregnancy. The assay, designed for use with PerkinElmer’s DELFIA Xpress table-top clinical instrument, detects levels of placental growth factor (PlGF). Reduced maternal serum concentration of PlGF is seen in a high proportion of pregnancies that go on to develop pre-eclampsia. The assay is not yet available in the US or Canada.